“Cipla today announced that its UK arm, Cipla EU has entered into definitive agreements to acquire two US-based companies, InvaGen Pharmaceuticals Inc, and Exelan Pharmaceuticals Inc,” said the Mumbai-based pharma company in its filing.
| Subscribe To Our Free Newsletter |
